PCYT2 and metabolic dysfunction-associated steatohepatitis: Importantly, nearly all DMGs that were also differentially expressed in Pcyt2 + /- were reversed to wild-type Pcyt2 + / + levels with PEA treatment, supporting our previous findings that PEA alters gene expression to ameliorate NASH.